Our findings provide another tool for understanding the allosteric activation of AMPK and suggest that the direct activation of AMPK is a promising approach for discovering novel therapies for the treatment of type 2 diabetes mellitus and metabolic diseases. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.